Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.0.1500627
European Journal of Endocrinology, Vol 150, Issue 5, 627-633
Copyright © 2004 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pascual, J.
Right arrow Articles by De Vivo, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pascual, J.
Right arrow Articles by De Vivo, D.
Articles

GLUT1 deficiency and other glucose transporter diseases

JM Pascual, D Wang, B Lecumberri, H Yang, X Mao, R Yang, and DC De Vivo

Colleen Giblin Laboratories, Neurological Institute of New York, College of Physicians and Surgeons, Columbia University, New York City, NY, USA. GiblinLabs@neuro.columbia.edu

We review the three genetically determined disorders of glucose transport across cell membranes. Diseases such as glucose-galactose malabsorption, Fanconi-Bickel syndrome and De Vivo disease (GLUT1 deficiency syndrome (GLUT1DS)) arise from heritable mutations in transporter-encoding genes that impair monosaccharide uptake, which becomes rate-limiting in tissues where the transporters serve as the main glucose carrier systems. We focus in greater detail on De Vivo disease as a prototype of a brain energy failure syndrome, for which the greatest pathophysiological detail is known, but which presents the most therapeutic challenges. The study of these diseases illustrates fundamental aspects of energetic metabolism, while providing the basis for their diagnosis by simple metabolic screening and for their treatment by dietary modification.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J. M. Pascual, D. Wang, R. Yang, L. Shi, H. Yang, and D. C. De Vivo
Structural Signatures and Membrane Helix 4 in GLUT1: INFERENCES FROM HUMAN BLOOD-BRAIN GLUCOSE TRANSPORT MUTANTS
J. Biol. Chem., June 13, 2008; 283(24): 16732 - 16742.
[Abstract] [Full Text] [PDF]

Home page
 JGPHome page
D. M. Blodgett, J. K. De Zutter, K. B. Levine, P. Karim, and A. Carruthers
Structural Basis of GLUT1 Inhibition by Cytoplasmic ATP
J. Gen. Physiol., July 30, 2007; 130(2): 157 - 168.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
J. M. Pascual, D. Wang, V. Hinton, K. Engelstad, C. M. Saxena, R. L. Van Heertum, and D. C. De Vivo
Brain Glucose Supply and the Syndrome of Infantile Neuroglycopenia
Arch Neurol, April 1, 2007; 64(4): 507 - 513.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
T. J. Urban, R. Sebro, E. H. Hurowitz, M. K. Leabman, I. Badagnani, L. L. Lagpacan, N. Risch, and K. M. Giacomini
Functional genomics of membrane transporters in human populations
Genome Res., February 1, 2006; 16(2): 223 - 230.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 European Society of Endocrinology.